{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:16:04Z","timestamp":1769598964828,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.yebeh.2017.08.026","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T05:45:19Z","timestamp":1505540719000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Real-world data on rufinamide treatment in patients with Lennox\u2013Gastaut syndrome: Results from a European noninterventional registry study"],"prefix":"10.1016","volume":"76","author":[{"given":"Marina","family":"Nikanorova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Auvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2017.08.026_bb0005","first-page":"S3","article-title":"All children who experience epileptic falls do not necessarily have Lennox\u2013Gastaut syndrome\u2026but many do","volume":"13","author":"Arzimanoglou","year":"2011","journal-title":"Epileptic Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2017.08.026_bb0010","first-page":"S15","article-title":"Evolution and management of Lennox\u2013Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue?","volume":"13","author":"Kerr","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0015","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox\u2013Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2017.08.026_bb0020","first-page":"S1","article-title":"Diagnosing and treating epileptic drop attacks, atypical absences and episodes of nonconvulsive status epilepticus","volume":"13","author":"Arzimanoglou","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/13543784.9.4.829","article-title":"An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development","volume":"9","author":"Jain","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2017.08.026_bb0030","first-page":"S27","article-title":"Rufinamide from clinical trials to clinical practice in the United States and Europe","volume":"13","author":"Resnick","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0035","author":"Eisai Ltd"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0040","author":"Eisai Inc"},{"issue":"Suppl. 10","key":"10.1016\/j.yebeh.2017.08.026_bb0045","article-title":"A European registry of antiepileptic drug use in patients with Lennox\u2013Gastaut syndrome","volume":"50","author":"Seeruthun","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yebeh.2006.10.010","article-title":"The development and validation of the epilepsy and learning disabilities quality of life (ELDQOL) scale","volume":"10","author":"Buck","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox\u2013Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2788.2009.01182.x","article-title":"Consensus guidelines into the management of epilepsy in adults with an intellectual disability","volume":"53","author":"Kerr","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejpn.2014.05.008","article-title":"Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines","volume":"18","author":"Coppola","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.2010.01334.x","article-title":"Adjunctive rufinamide in Lennox\u2013Gastaut syndrome: a long-term, open-label extension study","volume":"122","author":"Kluger","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.01.002","article-title":"Long-term safety and seizure outcome in Japanese patients with Lennox\u2013Gastaut syndrome receiving adjunctive rufinamide therapy: an open-label study following a randomized clinical trial","volume":"121","author":"Ohtsuka","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.yebeh.2010.01.005","article-title":"First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy","volume":"17","author":"Kluger","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.seizure.2010.09.008","article-title":"Rufinamide in children and adults with Lennox\u2013Gastaut syndrome: first Italian multicenter experience","volume":"19","author":"Coppola","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ane.12572","article-title":"Rufinamide in children and adults in routine clinical practice","volume":"135","author":"Jaraba","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pediatrneurol.2010.04.003","article-title":"Experience with rufinamide in a pediatric population: a single center's experience","volume":"43","author":"Vendrame","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clineuro.2012.09.021","article-title":"Effectiveness and tolerability of rufinamide in children and young adults with Lennox\u2013Gastaut syndrome: a single center study in Korea","volume":"115","author":"Lee","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1684\/epd.2010.0303","article-title":"The evolution of antiepileptic drug development and regulation","volume":"12","author":"Arzimanoglou","year":"2010","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.08.026_bb0110","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.0013-9580.2004.451101.x","article-title":"EURAP: an international registry of antiepileptic drugs and pregnancy","volume":"45","author":"Tomson","year":"2004","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017302950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017302950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T15:59:12Z","timestamp":1668787152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017302950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":22,"alternative-id":["S1525505017302950"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.026","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world data on rufinamide treatment in patients with Lennox\u2013Gastaut syndrome: Results from a European noninterventional registry study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}